CoreWeave Director Michael Intrator Files to Sell $14.2M in Stock Under 10b5-1 Plan
CRWV is trading near its 52-week low of $63.8 (6.3% above the low).
Summary
CoreWeave director and officer Michael Intrator filed to sell 200,000 shares worth $14.2 million under a 10b5-1 plan, continuing a pattern of significant insider sales.
Key Events · Ownership and Investor Activity · CRWV
-
Insider Sale Filing
Director and Officer Michael Intrator filed a Form 144 to sell 200,000 shares of CoreWeave common stock, valued at approximately $14.2 million based on recent prices.
-
10b5-1 Plan Execution
The sale is being executed under a pre-arranged 10b5-1 trading plan adopted on November 20, 2025, indicating the transaction was scheduled in advance rather than a discretionary move.
-
Ongoing Selling Pattern
Over the past three months, Intrator and related entities have sold 3,944,928 shares for total gross proceeds of $400,979,497.13, reflecting a sustained distribution of holdings.
-
Market Impact
The proposed sale represents a small fraction of CoreWeave's $36.7 billion market cap, but adds to the broader narrative of heavy insider selling at the company.
Analysis · CRWV · Technology
Michael Intrator, a director, officer, and 10% owner of CoreWeave, has filed a Form 144 to sell 200,000 shares worth approximately $14.2 million. The sale is part of a pre-existing 10b5-1 trading plan adopted in November 2025. While the dollar amount is significant, the sale represents a small fraction of the company's $36.7 billion market cap and follows a pattern of regular, planned sales by Intrator and related entities, which have already sold nearly 4 million shares for over $400 million in the past three months. The filing is notable given the ongoing heavy insider selling at CoreWeave, but the 10b5-1 plan structure and the modest size relative to the company's valuation temper its immediate market-moving potential.
At the time of this filing, CRWV was trading at $67.82 on NASDAQ in the Technology sector, with a market capitalization of approximately $36.7B. The 52-week trading range was $63.80 to $153.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.